Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 5 Uterine Cervical Neoplasms 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Phase IB 1 Pancreatic Neoplasms 1 Neoplasms 1 Multiple Myeloma 1 Mesonephric Gynecologic Cancer 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Low-Grade Serous Ovarian Cancer 1 Low Grade Serous Ovarian Cancer 1 Hematologic Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

defactinib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Low-Grade Serous Ovarian Cancer × defactinib × Gynecologic × Clear all

NCT06394804 2026-04-23

CHAMELEON

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting

Low-Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡